This approach can revolutionize traditional cytokine therapy by inducing safer and more efficient CTL immune responses against tumors by spatiotemporal integration of multivalent IL-15 self-transpresentation (MIST) and tumor antigen presentation. Here, IL15 is linked to neoplasm.